
Opinion|Videos|December 14, 2023
Bladder Cancer: Treatment Options and Managing Adverse Effects
Comprehensive insights on treatment considerations and managing immunotherapy-related adverse effects for patients with bladder cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic olaparib tablets across previously approved indications
2
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
3
FDA grants priority review to talazoparib plus enzalutamide for HRR gene-altered mCSPC
4
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
5












